FDA Inspection
Positive PromotionsPositive Promotions – FDA Inspection, Feb 7, 2025
Record Details
This FDA Inspection record concerns Positive Promotions, with an inspection on February 7, 2025, issued by the New York District Office, covering human drugs.
View Company Profile
ID · a8feaa8d-3d39-4d2e-805d-902ae4b98fdc
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1260232
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.25(a)GMP Training Frequency
- 21 CFR 211.84(d)(2)Reports of Analysis (Components)
- 21 CFR 211.188(b)(2)Identification of Equipment and Lines
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.100(a)Absence of Written Procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Positive Promotions
1| Date | Classification | Office | Project area |
|---|---|---|---|
| April 25, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Positive Promotions
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.